Rahul Rathod is a Cardiology physician affiliated with Boston Children's Hospital. OpenAlex indexes 163 publications with 2,674 citations (h-index 27); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- The Effect of Fontan Fenestration Closure on Hepatic Stiffness
Sponsor: Boston Children's Hospital
- Clinical Characteristics and Associations of the "Good Fontan" Patient
Sponsor: Boston Children's Hospital
- Fontan Imaging Biomarkers (FIB) Study
Sponsor: Boston Children's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PfizerProgram year20255 paymentsResearch$265,950openpaymentsdata.cms.gov ↗
- PfizerProgram year20247 paymentsResearch$388,800openpaymentsdata.cms.gov ↗
- PfizerProgram year20231 paymentResearch
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Beta blocker55.6%Carvedilol100%Part D<11 patientsAldosterone antagonist (MRA)44.4%Spironolactone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Risk Assessment and Prediction in Congenital Heart Disease Across the Lifespan
Journal of the American College of Cardiology
2024 - Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations in patients with congenital heart disease
Journal of Cardiovascular Magnetic Resonance
2024 - Impact of Age-Related Change in Caval Flow Ratio on Hepatic Flow Distribution in the Fontan Circulation
Circulation Cardiovascular Imaging
2024 - Thromboprophylaxis in Patients With Fontan Circulation
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Jane Newburger, MD
Boston Children's Hospital
Christopher Duggan, MD, MPH
Boston Children's Hospital
Samuel Nurko, MD
Boston Children's Hospital
Maureen Jonas, MD
Boston Children's Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”